AUG 22, 2016 07:36 PM PDT

Flesh-Eating Bacteria in Patients with Rheumatoid Arthritis

WRITTEN BY: Kara Marker
A compound produced by the immune system triggers the recruitment of immune cells during an infection, but only with the proper signaling from other immune cells. However, recent research findings show that certain bacterial species can also activate the same compound. 
Credit: UC San Diego Health
Interleukin-1beta (IL-1beta) is first produced by the immune system as a long and inactive compound that requires cleavage for activation. While the body uses the inflammasome to cleave and activate IL-1beta, Group A Streptococcal bacteria produces its own enzyme called SpeB to do the same, which scientists from the University of California San Diego found in their recent study, published in the journal Science Immunology.

While it might seem counterintuitive that natural selection would favor a bacterial species that practically warned the host’s immune system of its presence, researchers from the study believe that the technique is to “wipe out competing bacteria” so Streptococcus can enter and dominate. 

First author Christopher LaRock, PhD said it also makes sense to for bacteria to inhibit SpeB production: “This finding may explain why some of the more invasive, flesh-eating strep strains have a genetic mutation that blocks SpeB production; it helps them avoid tripping the alarm and setting off an immune response.”

LaRock and the team analyzed data from a U.S. Food and Drug Administration database, looking for rheumatoid arthritis patients with extreme infections who also were known to be taking anakinra, an immunosuppressant drug that works by inhibiting IL-1beta activity. According to their findings, rheumatoid arthritis patients taking the drug were 300 times more likely than patients not taking the drug to experience “invasive, flesh-eating strep infections” from Group A Streptococcus species.

“With IL-1beta out of the picture, as is the case with patients taking anakinra, strep strains can progress to invasive infection while producing SpeB, which goes unnoticed by the immune system," LaRock said.

This study simultaneously revealed how vital IL-1beta is to effective immune protection and how important it is for doctors to consider doses and types of immunosuppressive drugs they give to patients. Rheumatoid arthritis is one of many autoimmune disorders that occur because of an overreaction of the immune system. While drugs that inhibit IL-1beta might help with flares of rheumatoid arthritis, infections with intense flesh-eating bacteria aren’t the right solution either. Doctors have to find a balance, including “close-monitoring and prophylactic antibiotics.”
 


Source: University of California San Diego
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Immunology
SEP 17, 2019
Unleashing the Immune System on Cancer
A team of international researchers has discovered that there may me a more from the immune system to aid in the battle against cancer...
SEP 17, 2019
Immunology
SEP 17, 2019
If I Only Had a Brain
Research scientists have demonstrated that immune cells make brain chemicals to fight off infections....
SEP 17, 2019
Drug Discovery
SEP 17, 2019
Combination Immunotherapy Stops Liver Cancer Growth
The number of individuals diagnosed with liver cancer is on the rise and current therapies are largely ineffective. However, new preclinical data from the ...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Drug-resistant Candida Auris is Spreading
A drug-resistant fungal yeast, Candida auris, is spreading throughout hospitals worldwide. Deemed “an urgent threat” by the Center for Disease...
SEP 17, 2019
Cell & Molecular Biology
SEP 17, 2019
Getting Rid of Damaged Mitochondria Relieves Autoimmune Disease in Mice
Scientists have found a way to inhibit inflammatory molecules that are linked to diseases like lupus and osteoarthritis....
Loading Comments...